NLRP3炎症酶触发阻断性睡眠呼吸暂停的炎症
Xiaoting Yangzhong1,2, Shu Hua1, Yiqiong Wen1
1Department of Pulmonary and Critical Care Medicine, First Affiliated Hospital, Kunming Medical University, Kunming, China.
Current molecular medicine
|May 17, 2024
概括
阻塞性睡眠呼吸暂停 (OSA) 涉及呼吸控制问题,导致炎症. 由OSA激活的NLRP3炎症酶驱动严重的健康并发症,如糖尿病和心脏病.
科学领域:
- 睡眠医学 睡眠医学
- 免疫学 免疫学 免疫学
- 心血管疾病 心血管疾病
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 影响全球10亿人,与呼吸控制功能障碍有关.
- OSA会导致间歇性缺氧 (IH),高头和氧化应激 (OS).
- 在IH,超,和OS之后,观察到NOD类受体家族的pyrin域含有 (NLRP3) 炎症酶的增加.
研究的目的:
- 审查NLRP3炎症酶的结构和功能.
- 为了阐明NLRP3炎症和OSA之间的关联.
- 探索NLRP3炎症酶在OSA相关并发症中的作用.
主要方法:
- 文献综述侧重于NLRP3炎症酶.
- 分析了将OSA,炎症和疾病并发症联系在一起的研究.
- 对NLRP3炎症酶通路的当前研究的综合.
主要成果:
- NLRP3炎症酶激活是OSA的关键炎症反应.
- NLRP3炎症酶有助于与OSA相关的疾病,如2型糖尿病 (T2DM),冠状动脉心脏病 (CHD),高血压,神经炎症和抑郁症.
- 通过NLRP3炎症酶激活IL-1β和IL-18,可以介导炎症性疾病.
结论:
- 在OSA的病理生理学中,NLRP3炎症酶是关键的调解者.
- 准NLRP3炎症酶可能为OSA及其并发症提供治疗策略.
- 了解NLRP3炎症酶的作用对于管理与OSA相关的并发症至关重要.
相关概念视频
01:24Sleep-Wake Cycles
1.3K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.3K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
424
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
424